Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aquestive Therapeutics Inc (AQST)
Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,156
  • Shares Outstanding, K 54,156
  • Annual Sales, $ 47,680 K
  • Annual Income, $ -54,410 K
  • 60-Month Beta 2.69
  • Price/Sales 1.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AQST with:

Options Overview Details

View History
  • Implied Volatility 258.89% ( +258.89%)
  • Historical Volatility 67.97%
  • IV Percentile 57%
  • IV Rank 15.05%
  • IV High 1,436.64% on 06/16/22
  • IV Low 50.22% on 06/14/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 59
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,099
  • Open Int (30-Day) 976

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate -0.30
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +53.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7200 +59.72%
on 03/15/23
1.1500 unch
on 03/30/23
+0.3675 (+46.96%)
since 02/28/23
3-Month
0.7200 +59.72%
on 03/15/23
1.1500 unch
on 03/30/23
+0.3773 (+48.83%)
since 12/28/22
52-Week
0.6180 +86.08%
on 07/01/22
2.7800 -58.63%
on 03/30/22
-1.4800 (-56.27%)
since 03/28/22

Most Recent Stories

More News
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -9.52% and 7.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

AQST : 1.1500 (+15.00%)
ONCT : 0.8150 (+8.44%)
Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics: Q4 Earnings Snapshot

AQST : 1.1500 (+15.00%)
Assertio (ASRT) Reports Next Week: Wall Street Expects Earnings Growth

Assertio (ASRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASRT : 6.41 (+1.75%)
AQST : 1.1500 (+15.00%)
Aquestive Therapeutics (AQST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Aquestive Therapeutics (AQST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AQST : 1.1500 (+15.00%)
Assertio (ASRT) to Report Q4 Earnings: What's in the Cards?

On Assertio Holdings' (ASRT) Q4 earnings call, investors will focus on the sales performance of its marketed products.

ALKS : 27.82 (-0.36%)
BAYRY : 15.8600 (+1.93%)
ASRT : 6.41 (+1.75%)
AQST : 1.1500 (+15.00%)
Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 23.33% and 7.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AQST : 1.1500 (+15.00%)
IMGN : 3.71 (-3.13%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 1.1500 (+15.00%)
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space

Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...

AQST : 1.1500 (+15.00%)
Pacira's (PCRX) Q2 Earnings Miss Estimates, Revenues Rise Y/Y

Pacira's (PCRX) earnings and revenues fall shy of estimates in the second quarter of 2022.

PCRX : 40.18 (-1.45%)
AQST : 1.1500 (+15.00%)
VRCA : 6.64 (+0.30%)
TCRT : 0.6594 (+3.02%)
Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Transcript

AQST earnings call for the period ending June 30, 2022.

AQST : 1.1500 (+15.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 1.3500
2nd Resistance Point 1.2500
1st Resistance Point 1.2000
Last Price 1.1500
1st Support Level 1.0500
2nd Support Level 0.9500
3rd Support Level 0.9000

See More

52-Week High 2.7800
Fibonacci 61.8% 1.9541
Fibonacci 50% 1.6990
Fibonacci 38.2% 1.4439
Last Price 1.1500
52-Week Low 0.6180

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar